Santaris Pharma

Acquired

Copenhagen, Denmark · Founded 2003

Headquarters
Copenhagen
Founded
2003
Business Model
B2B
Last Round
Venture RoundJun 2012
Rounds
2
Acquisition Date
Aug 2014

About

Santaris Pharma A/S was a Copenhagen, Denmark-based biopharmaceutical company founded in 2003 through the merger of Cureon and Pantheco, with a second research site opened in San Diego in 2009. The company developed RNA-targeted medicines using its proprietary Locked Nucleic Acid (LNA) Drug Platform, advancing candidates for cancer, hepatitis C, and cardiometabolic disease, and partnering with Pfizer, GlaxoSmithKline, Shire, Enzon, and Bristol-Myers Squibb. In August 2014, Roche acquired Santaris for up to $450 million, renaming the Copenhagen site the Roche Innovation Center Copenhagen, which was fully closed in 2023 when Roche consolidated RNA research in Basel.

Summary

Santaris Pharma is a Biotech company based in Copenhagen, Denmark, founded in 2003. Its most recent funding was a Venture Round round in Jun 2012. Investors include Forbion Capital Partners, Roche and Gilde Healthcare.

Funding History

AcquisitionAug 2014

Sign up to see all 3 rounds

Venture Round through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Santaris Pharma on Indexed.vc
<a href="https://indexed.vc/companies/santaris-pharma"><img src="https://indexed.vc/api/badge/company/santaris-pharma" alt="Santaris Pharma on Indexed.vc" width="260" height="76" /></a>